BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Feb. 13, 2002
View Archived Issues
NeuroSearch, Ingelheim Enter $80M Alliance Around NS2330
Shares in NeuroSearch A/S surged more than 50 percent Friday on news of its largest ever deal, a US$80 million pact with Boehringer Ingelheim GmbH to develop its candidate Alzheimer’s and Parkinson’s drug, NS2330. (BioWorld International)
Read More
Irish Government Backs EUR15M Biotech Life Sciences Seed Fund
Read More
Genetic Tests Predict Cancer Risks, Melanoma Study Shows
Read More
EU Officials Want Legislation Covering Tissue, Cell Implants
Read More
Proteom Raises £3M To Further Work Around Protein Interactions
Read More
Other News To Note
Read More
Transgene Says Restructuring In Place, Products Moving Along
Read More
Scancell Partners Antibody Drug In Asia With Korean Company
Read More
Metabolic Eyeing Phase IIb Trial In Obesity After Positive IIa Study
Read More